Compare ESQ & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESQ | ARCT |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.2M | 194.1M |
| IPO Year | 2017 | N/A |
| Metric | ESQ | ARCT |
|---|---|---|
| Price | $108.64 | $6.48 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $113.00 | $38.67 |
| AVG Volume (30 Days) | 69.1K | ★ 820.7K |
| Earning Date | 01-22-2026 | 11-10-2025 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | ★ 14.70 | N/A |
| EPS | ★ 5.68 | N/A |
| Revenue | ★ $131,743,000.00 | $97,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.55 | N/A |
| P/E Ratio | $18.62 | ★ N/A |
| Revenue Growth | ★ 13.37 | N/A |
| 52 Week Low | $68.90 | $5.85 |
| 52 Week High | $108.70 | $24.17 |
| Indicator | ESQ | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 67.30 | 34.96 |
| Support Level | $105.33 | $7.04 |
| Resistance Level | $108.70 | $7.76 |
| Average True Range (ATR) | 2.83 | 0.44 |
| MACD | 0.30 | 0.24 |
| Stochastic Oscillator | 94.52 | 23.98 |
Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.